Bot Detector
LEARN MORE
A subscription to
IJPC
provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.
LEARN MORE
Sign On
The Journal
Editor-In-Chief
Editorial Calendar
Submissions
Advertising
Permissions & Reprints
Privacy Policy
Contact Us
Subscribe
Renew
Prices
Free Sample
View Cart
Articles
Issues
Archives
Supplemental Content and Errata
Training and Education
IJPC-PCAB SOP Matrix
USP GAP Analysis
Compounders' Network List
Patient Information
Videos
Compounders' Resource Directory
Nov/Dec 2016- Volume 20, Number 6
Purchase the entire back issue in electronic PDF or print format.
(Select Format)
Print Copy — $95
PDF — $95
Purchase individual articles by selecting the article in the table below...
Individual Articles - Nov/Dec 2016- Volume 20, Number 6
Title/Author
(Click for Abstract / Details / Purchase)
Issue/Page
View/Buy
PreScription: Two Decades of IJPC
Allen Loyd V Jr
Nov/Dec 2016
Pg. 444
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Deleruyelle Laura J
Nov/Dec 2016
Pg. 447-454
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)
Nov/Dec 2016
Pg. 457-458
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Karara Adel H
,
Hines Ryan
,
Demir Zehra
,
Nnorom Bethran
,
Horsey Robert
,
Twigg Geoffrey
Nov/Dec 2016
Pg. 461-467
Why Become Pharmacy Compounding Accreditation Board Accredited?
Dillon L Rad
Nov/Dec 2016
Pg. 469-474
The "Lists": What Do They Mean?
Voliva John
Nov/Dec 2016
Pg. 477-479
Introduction to Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
Nov/Dec 2016
Pg. 481-484
Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
Nov/Dec 2016
Pg. 485-493
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
Nov/Dec 2016
Pg. 495-500
Calculations
Stockton Shelly J
Nov/Dec 2016
Pg. 502
Alendronate 70-mg/75-mL Drinkable Formulation
Allen Loyd V Jr
Nov/Dec 2016
Pg. 504
Bosentan 6.25-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 505
Capsaicin 0.025% and Doxepin 3.3% Cream
Allen Loyd V Jr
Nov/Dec 2016
Pg. 506
Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel
Allen Loyd V Jr
Nov/Dec 2016
Pg. 507
Erlotinib 10-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 508
Flumazenil 0.1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2016
Pg. 509
Imatinib 40-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 510
Lapatinib Ditosylate 50-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 511
Melatonin 2-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 512
Menthol, Chloral Hydrate, and Camphor Analgesic Ointment
Allen Loyd V Jr
Nov/Dec 2016
Pg. 513
Stability of Fentanyl Citrate in Polyolefin Bags
Donnelly Ronald F
Nov/Dec 2016
Pg. 514-516
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial
Rabi Joseph
,
Minori Joshua
,
Abad Hasan
,
Lee Ray
,
Gittler Michelle
Nov/Dec 2016
Pg. 517-520
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature
Larson Bayli
,
Bushman Lane R
,
Casciano Matthew L
,
Oldland Alan R
,
Kiser Jennifer J
,
Kiser Tyree H
Nov/Dec 2016
Pg. 521-525
PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution
Rost Erika
Nov/Dec 2016
Pg. 526-527
Return to Top